BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6196420)

  • 1. The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes.
    Ansel JC; Luger TA; Green I
    J Invest Dermatol; 1983 Dec; 81(6):519-23. PubMed ID: 6196420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro.
    Gahring L; Baltz M; Pepys MB; Daynes R
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1198-202. PubMed ID: 6608106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of animals to the inflammatory effects of ultraviolet radiation is mediated through mechanisms which are distinct from those responsible for endotoxin tolerance.
    Gahring LC; Daynes RA
    J Immunol; 1986 Apr; 136(8):2868-74. PubMed ID: 2420872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF).
    Sauder DN; Noonan FP; DeFabo EC; Katz SI
    J Invest Dermatol; 1983 Jun; 80(6):485-9. PubMed ID: 6222123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line.
    Luger TA; Stadler BM; Luger BM; Sztein MB; Schmidt JA; Hawley-Nelson P; Grabner G; Oppenheim JJ
    J Invest Dermatol; 1983 Sep; 81(3):187-93. PubMed ID: 6604110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrocortisone reduces both constitutive and UV-elicited release of epidermal thymocyte activating factor (ETAF) by cultured keratinocytes.
    Kupper TS; McGuire J
    J Invest Dermatol; 1986 Nov; 87(5):570-3. PubMed ID: 3534102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.
    Luger TA; Stadler BM; Luger BM; Mathieson BJ; Mage M; Schmidt JA; Oppenheim JJ
    J Immunol; 1982 May; 128(5):2147-52. PubMed ID: 6801132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF).
    Breathnach SM; Katz SI
    J Invest Dermatol; 1985 Dec; 85(6):553-8. PubMed ID: 3877770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activating factor: implications for skin aging.
    Sauder DN; Stanulis-Praeger BM; Gilchrest BA
    Arch Dermatol Res; 1988; 280(2):71-6. PubMed ID: 3260767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine-induced inhibition of the production of interleukin 1-like epidermal cell-derived thymocyte activating factor.
    Enk C
    J Invest Dermatol; 1989 Aug; 93(2):268-71. PubMed ID: 2787824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
    Luger TA; Sztein MB; Schmidt JA; Murphy P; Grabner G; Oppenheim JJ
    Fed Proc; 1983 Jul; 42(10):2772-6. PubMed ID: 6602721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activity.
    Danner M; Luger TA
    J Invest Dermatol; 1987 Apr; 88(4):353-61. PubMed ID: 2435814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and modulation of IL-1 alpha in murine keratinocytes.
    Ansel JC; Luger TA; Lowry D; Perry P; Roop DR; Mountz JD
    J Immunol; 1988 Apr; 140(7):2274-8. PubMed ID: 3258334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunomodulation using an epidermal cytokine (ETAF)].
    Luger TA; Niebauer G
    Z Hautkr; 1984 Jan; 59(1):18, 23-34. PubMed ID: 6367244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of immunoregulatory cytokines produced by epidermal cells.
    Luger TA; Köck A; Danner M
    Scand J Immunol; 1985 May; 21(5):455-62. PubMed ID: 3890150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenicity and metastatic behavior in nude mice of two human squamous cell carcinoma lines that differ in production of the cytokine ETAF/IL-1.
    Price JE; Sauder DN; Fidler IJ
    J Invest Dermatol; 1988 Sep; 91(3):258-62. PubMed ID: 3045210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).
    Luger TA; Stadler BM; Katz SI; Oppenheim JJ
    J Immunol; 1981 Oct; 127(4):1493-8. PubMed ID: 6974195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
    Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
    J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation.
    Kupper TS; Chua AO; Flood P; McGuire J; Gubler U
    J Clin Invest; 1987 Aug; 80(2):430-6. PubMed ID: 3497177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.